Taylor Morrison Home clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Taylor Morrison Home Corporation
TMHC · the NYSE · USD · Market cap $6.8B · 2,800 employees
Taylor Morrison Home Corporation, together with its subsidiaries, operates as a homebuilder and land developer in the United States.
Not yet scoredPrice as of 11 Sep 2026Daily close, not a live quoteLast reviewed 55 days ago
Screened 2026-09-11 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price72.45 USD at the 11 Sep 2026 close
- Fair valueUnder review: its inputs are 55 days old.
- Our regime readMarkup, as of 1 Nov 2026
- Ethical screenNot yet scored
- Last reviewed11 Sep 2026 (55 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
Our fair-value range: range not available (screen dated 2026-09-11).
- Trend Markup
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
This name holds its markup label.
Taylor Morrison Home Corporation holds its Markup at $72.45. Consolidating, no directional conviction, held for 6 days.
| Phase | Markup |
| Quantitative state | Consolidating, no directional conviction, held for 6 days |
| Price at the screen | $72.45 |
| Valuation | 10.80 trailing · 11.53 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 1.44 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 24.02% | Below 33% | Interest-bearing debt is just 24.0% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 0.00% | Below 33% | Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit. | Pass |
| Receivables | 11.10% | Below 49% | Money owed to the company is 11.1% of assets, under the 49% limit. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
Taylor Morrison Home clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
Taylor Morrison Home clears all five screens. Its business is in a permissible area, its interest-bearing debt is about 24%, inside the ~33% line, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Its inputs are 55 days old. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets: 4 covering, consensus Hold. The average target sits +0% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-09-11 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain WordsHomebuilder Sells at a Premium to Value
Picture a family signing for their first home in Phoenix just as mortgage rates climb and buyer traffic slows. Taylor Morrison builds those houses across the Sun Belt, yet the numbers show revenue dropping 27 percent and a forward multiple of 11.3 times that flatters peak-cycle earnings. We pass because the shares sit 10 percent above our fair value and the business carries no clear moat in a market that has already turned.
The low multiple looks tempting until you remember this is residential construction. Profit margins sit at 9 percent and return on equity at 11 percent, both typical for the sector near the top of a housing cycle. When volumes fall further the same earnings can compress quickly, turning an apparently cheap multiple into a value trap rather than a bargain.
Ethical checks clear and four analysts sit on hold with a 72 dollar median target, but that consensus simply mirrors the current price and offers no margin of safety. Currency or regulatory shocks are absent here; the real exposure is to interest rates and consumer confidence that remain outside the company's control. Analysis, not advice.
| Forward P/E | 11.5xreasonably valued |
| Trailing P/E | 10.8xreasonably valued |
| EPS, trailing | 6.71 |
| EPS, forward | 6.29 |
| Revenue growth | -26.8%revenue is shrinking |
| Profit margin | 8.8%thin but positive margins |
| Return on equity | 11.1%a modest return on shareholder capital |
| FCF yield | 7.56% |
| Debt to equity | 0.39minimal debt: a conservative balance sheet |
| Current ratio | 9.26comfortably covers its short-term bills |
| Beta | 1.44moves a little more than the market |
| Short interest, float | 0.04% |
| 52-week range | 54.15 - 72.50 |
| Market cap | $6.8B |
| Employees | 2,800 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it already moves more than the market on an average day.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeTMHC trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading overbought. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
The framework has shifted from markdown to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 0.8% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are up 20%. Our forward projection puts the odds of a 10% gain over the next month near 19%. The street (9 analysts) rates it buy, with a mean price target of $70.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- Greg Abel Closed Berkshire Hathaway's Taylor Morrison Deal on July 24. Here's What Berkshire Owns Now. Motley Fool · 3 Aug 2026
- Taylor Morrison Home Shareholders Approve Berkshire Hathaway Merger MarketBeat · 23 Jul 2026
- Why Tutor Perini Stock Trounced the Market on Tuesday Motley Fool · 21 Jul 2026
- Why There’s a Big Battle for This Small Home Builder Barrons.com · 14 Jul 2026
- Berkshire Hathaway's $8.5 Billion Housing Bet Faces a Shareholder Vote on July 22. Here's What's at Stake. Motley Fool · 11 Jul 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $59.30 | +20.7% | · | $1,207 | +20.7% |
| 2 months | $59.41 | +20.5% | · | $1,205 | +20.5% |
| 3 months | $58.86 | +21.6% | · | $1,216 | +21.6% |
| 6 months | $63.03 | +13.6% | · | $1,136 | +13.6% |
| 1 year | $59.70 | +19.9% | · | $1,199 | +19.9% |
| 2 years | $56.11 | +27.6% | · | $1,276 | +27.6% |
| 3 years | $46.70 | +53.3% | · | $1,533 | +53.3% |
| 5 years | $27.87 | +156.9% | · | $2,569 | +156.9% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever TMHC does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.